CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for ProPhase Labs Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

ProPhase Labs Inc
711 STEWART AVE, SUITE 200, GARDEN CITY
Phone: (215) 345-0919p:215 345-0919 NEW YORK, NY  11530  United States Ticker: PRPHPRPH
Business Summary
ProPhase Labs, Inc. is a biopharma, genomics, and diagnostics company. The Company provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its segments include diagnostic services and consumer products. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services. Its CLIA labs and diagnostic technology provide wellness solutions.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes--Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Ted W.Karkus 63 7/17/2009 5/20/2009
Chief Operating Officer Jed A.Latkin 1/1/2024 1/1/2024
Independent Director Jason M.Barr 43 6/1/2015 6/1/2015
Independent Director LouisGleckel 67 6/1/2009 6/1/2009
Independent Director WarrenHirsch 65 1/1/2019 1/1/2019

Subsidiaries
Business Name Address City State/Province Country
Nebula Genomics, Inc. 1600 NE 1st Avenue Miami FL United States
Confucius Plaza Medical Laboratory Corp. 42 Throckmorton Lane Old Bridge NJ United States
Pharmaloz Manufacturing, Inc. 500 N 15th Ave Lebanon PA United States

Business Names
Business Name
Confucius Plaza Medical Laboratory Corp.
Nebula Genomics, Inc.
Pharmaloz Manufacturing Inc.
11 additional Business Names available in full report.

General Information
Number of Employees: 113 (As of 12/31/2023)
Outstanding Shares: 18,045,209 (As of 3/15/2024)
Shareholders: 162
Stock Exchange: NASD
Federal Tax Id: 232577138
Email Address: QUIGLEY@WWW.QUIGLEY.COM


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 15, 2024